NEW YORK (GenomeWeb) – RNAi contract research firm Cenix Bioscience is shutting down, according to a statement on the company's website.
Cenix CEO and CSO Christopher Echeverri confirmed the situation, but declined to comment further.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.
The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.
Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.
In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.
This webinar will provide an overview of alternatives to the popular Cas9 nuclease used in CRISPR gene editing.